Antigenic properties of Getah virus were monitored during 80 serial passages in Vero tissue cultures. The parent virus lost its serotype identity by passage 80. A clone derived from the parent remained antigenically stable during passage. The experimentally induced antigenic alterations in Getah virus were attributable to the tissue culture host selection of constituent subpopulations of virus with properties unlike those of the original parent. The marked differences in neutralization titers of low-and high-passage virus were considered related to or influenced by (i) the variation in subpopulation selection of the virus during passage and (ii) the variation in availability of antigenic stimulants during preparation of antiserum.
Antigenic heterogeneity of the various constituent virus particles comprising a virus strain has been well established for certain enteroviruses (3), myxoviruses (4, 5), and representative arboviruses (9, 10, 27) . The (14) or by LD5o determinations in infant mice (20) . The ICR strain of specific pathogenfree mice was used for preparing virus stocks.
Virus clone. Techniques for cloning viruses by plaque purification have been detailed previously (5). Getah virus (Sagiyama strain) was cloned by three successive plaque-picking and plating procedures. Care was taken to wash cultures at least five times with saline after virus adsorption. At each purification step, plaques were picked from those bottles containing less than 10 plaques.
Tissue culture. A passage line of Vero green monkey kidney cells (24) was used throughout. Stock cells were grown in Eagle's basal medium containing 5% fetal bovine serum and were maintained by using the same medium but with the calf serum concentration reduced to 2%c. Tube and bottle cultures were prepared from cell culture stocks in passage generations 135 to 171. All cultures used were free from endogenous mycoplasma contaminants. with each virus antigen. Antisera from animals of a group were pooled and frozen in 0.5-ml samples at about -80 C in a mechanical freezer until used. A fresh ampoule of antiserum was thawed each time tests were performed.
Filtration of viruses. A 10% suspension of parent Getah virus (Sagiyama strain) of mouse brain source was passed through a 220-nm (APD) membrane filter (Millipore Corp., Bedford, Mass.), and then the filtrate was refiltered through a 100-nm membrane. Undiluted infected tissue culture fluids were filtered in a similar manner. Membranes were "primed" with calf serum before filtration of virus suspensions to avoid excessive adsorption of virus to the filter and consequent loss of titer (16) . General methods and equipment used in filtration experiments were similar to those described previously (15) .
Neutralization tests. Two types of plaque-reduction neutralization tests were used in experiments, the varying virus method and the varying serum technique.
All tests were performed in 2-oz (ca. 60 ml) plastic bottle cultures of Vero cells. The varying virus method was similar to that described previously (10) . In one test, each antiserum was mixed with an equal volume of various log dilutions of virus. The virus-serum mixtures were incubated at 37 C for 1 hr, the bottles were inoculated, the inoculum was adsorbed for 1 hr, and all cultures were overlaid (15) . In the second test, the varying serum method, procedures were essentially the same as described by Russell and Nisalak (22) . Twofold serum dilutions were used, and three replicate cultures were run for each dilution. Data were expressed as the reciprocal serum dilution giving 50% plaque reduction (7) .
Hemagglutination-inhibition test. The standard hemagglutination-inhibition test for arboviruses was employed (6) . Antisera were treated with kaolin to remove nonspecific hemagglutinin inhibitors. Hemagglutinating antigens were prepared from infected mouse brain (6) Antigenic status of Getah virus clone during serial passage in tissue culture. A clone derived from the parent Sagiyama strain of Getah virus was taken 80 passages in Vero tissue culture. As with the parent, the virus titer and neutralization test titer were determined at each passage level. There was essentially no change in the neutralization titer during passage, even though, as in the case of the parent, infectivity titers varied considerably (Fig. 2) . Log values ranged from 2.4 to 3.1, with passage 1 virus having a titer of 2.8 and passage 80 a titer of 2.9. Again, as with the parent virus series, infectivity titers varied independently of neutralization titers.
Neutralization tests with filtered Getah parent viruses. Neutralization tests were performed by using filtered Getah parent (Sagiyama strain) and a tissue culture passage (TC-81) of this virus. It was thought that perhaps one explanation for the marked discrepancy in log neutralization indexes between mouse brain parent source and the high tissue culture-passaged parent was due to the difference in the non-neutralizable persistent fraction of the mouse brain parent virus, which might have been attributable to virus aggregation Neutralization rate of parent and tissue culturepassaged Getah virus. The rate of inactivation of the parent and tissue culture-passaged virus (both unfiltered) was studied by using antiserum prepared against the mouse brain parent Sagiyama strain (Fig. 3) tests were performed by using other serotypes of the group A "complex" of which Getah is a member. Viruses and antisera of Getah parent, Getah TC-81, Bebaru, Ross River, Semliki Forest, Chikungunya, O'nyong nyong, Mayaro, and Una were tested by plaque-reduction neutralization (Fig. 4) . Criteria for antigenic relatedness or distinctness were the same as established previously (9) . Antisera prepared against Getah TC-81 failed to neutralize significantly any of the serogroup "complex" viruses, but Getah TC-81 virus was significantly neutralized by Getah parent, Ross River, Chikungunya, and Mayaro viruses. Thus, Getah TC-81 virus shares less of an antigenic relationship (a probable loss in subpopulation antigen types) with other serotypes of the "complex" than the serotypes share with one another. A simplified diagram of such antigenic relationships, taken from the data of Fig. 4, is shown in Fig. 5 . These relationships were established on the basis of two-way cross-neutralization by using hyperimmune sera. Getah TC-81 has no place in this relationship scheme among viruses of this serogroup complex, indicating further the distinctness of its antigenic property.
DISCUSSION
In a recent report, Ozaki and Kumagai (19) described alterations in the antigenic properties of Japanese encephalitis virus after 29 passages in cultures of a stable line of porcine kidney cells. They found, as was the case in these experiments, that the amount of virus neutralized by certain antisera was much less with low-passage than with high-passage virus ( Fig. 1 and Table 3 ). These workers also found this neutralization phenomenon obtained by passage of the virus to occur when plaque-purified virus was passaged. This finding is in contrast to our results; no changes in neutralizing properties were observed by tissue culture passage of our clone (Fig. 2) (Tables 3 and 4 ) and related serotypes (Fig. 4) would indicate that the high-passage virus is sufficiently distinct by existing criteria to justify designating it a new serotype. Thus, on the basis of this experimental model, it may be possible to change significantly the antigenic properties of other arbovirus serotypes by using the proper host and a suitable number of passages. Results of host passage could culminate in an arbovirus with distinct serotype properties as shown here or with antigenic properties more related to known serotypes other than the parent from which it was derived (T. B. Stim and J. R. Henderson, Bacteriol. Proc., p. 182, 1968).
One can only speculate regarding the significance or importance of these phenomena in the natural evolvement of new arbovirus serotypes. Because of the close antigenic relationships of certain viruses, it is very possible that some strains may be comprised of the same subpopulations in different concentrations and are thus expressed in different ways, as proposed before (12) . However, it is now possible to experimentally induce heretofore unknown arbovirus serotypes from known ones by host selection techniques, and it may be possible to revert the new virus back to the original parent type under suitable experimental conditions and if there was no loss in the original antigenic subpopulation components during passage.
